NDC 50090-3701

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-3701Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-3701Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-3701-0	50090370100	30 TABLET, FILM COATED in 1 BOTTLE (50090-3701-0)Marketed from Oct 9, 2019
50090-3701-1	50090370101	90 TABLET, FILM COATED in 1 BOTTLE (50090-3701-1)Marketed from Oct 22, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Olmesartan Medoxomil and Hydrochlorothiazide
Generic name (nonproprietary): olmesartan medoxomil and hydrochlorothiazide
Active ingredients: Olmesartan medoxomil — 20 mg/1Hydrochlorothiazide — 12.5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205391
Marketing start: Apr 24, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 50090-3701_0a66c75f-394d-4ce8-9eb7-79cbbb12a584SPL ID 0a66c75f-394d-4ce8-9eb7-79cbbb12a584SPL set ID b78ad43f-f132-4f03-8c85-2cf9b3ab555bRxCUI 403853UNII 6M97XTV3HD, 0J48LPH2TH
Pharmacologic class: Angiotensin 2 Receptor Blocker; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090370100 followed by a unit qualifier and the quantity

Package 50090-3701-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 30, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Olmesartan medoxomil and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Olmesartan medoxomil and hydrochlorothiazide tablets are not indicated for the initial therapy of hypertension [see Dosage and Administration (2) ]. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil and hydrochlorothiazide …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205391

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205391
Product	Strength	Form · route	Labeler	Product NDC
Olmesartan Medoxomil and Hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-0845
Olmesartan Medoxomil and Hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-4377
Olmesartan Medoxomil and Hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-780
Olmesartan Medoxomil and Hydrochlorothiazide	Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-779
Olmesartan Medoxomil and Hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-781
Olmesartan Medoxomil and Hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-3561

Olmesartan Medoxomil and Hydrochlorothiazide NDC 50090-3701